Gadong, Sittie Fatima -.

HRN: 23-93-00  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/19/2022
CEFUROXIME 1.5GM (VIAL)
09/19/2022
09/26/2022
IVTT
350mg
Q8
UTI
Waiting Final Action 
09/20/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/20/2022
09/27/2022
IV
150mg
Q8
Abdominal Obstruction
Waiting Final Action 
09/23/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/23/2022
09/30/2022
IV
600mg
Q8h
T/C Sepsis
Waiting Final Action 
09/26/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
09/26/2022
10/03/2022
PO
5.6 Ml
Q8
Amoebisais
Waiting Final Action 
09/26/2022
CEFIXIME 100MG/5ML, 60ML SUSPENSION (BOT)
09/26/2022
10/03/2022
PO
5.25 Ml
Q12
Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: